Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk

Abstract

3-β-hydroxysteroid dehydrogenase 1 (HSd3B1) is shown to affect dihydrotestosterone level in prostatic tissue which is a risk factor for prostate cancer (Pc). The present study aimed to determine whether rs33937873 (G313a) and rs6203 (c338T) single nucleotide polymorphisms (SnP) in HSd3B1 gene was a potential risk factor for Pc susceptibility and can predict the recurrence of Pc in egyptian patients. a total of 186 egyptian patients were selected with incident primary Pc and compared with 180 age healthy controls. The frequencies and the main effect of rs33937873 and rs6203 in HSd3B1 were compared and investigated between the patients and control using genotyping technique and statistical analysis. The mutant Ga genotype of G313a in rs33937873 SnP was considered as an independent risk for Pc in the multivariate regression analysis [odds ratio (OR)=2.7, 95% confidence intervals (CI): 1.2-5.5, P=0.01] together with positive history of hypertension (HTn) (or=6.2, 95% ci: 3.2-12.1, P=0.0001) and begin prostatic hyperplasia (BPH; or=8.9, 95% ci: 4.5-17.5, P=0.0001). conversely, in rs6203 (c338T), c allele is considered as major risk allele in the development of Pc (or=1.8, P=0.0003). The univariate logistic regression analyses indicated that cc genotype of rs6203 was a Pc risk factor (or=1.9, 95% ci: 1.3-2.9, P=0.002). in addition, the frequency of the a-c haplotype established by rs33937873-rs6203 was also significantly higher for PC (P= 0.013). The predication of Pc recurrence was associated only with positive family history (or=7.7, 95% ci: 2.3-25.9, P=0.001) and not for The G313a and c338T SnPs. These results suggested that the two HSd3B1 polymorphisms rs33937873 and rs6203 may modify the risk of Pc, particularly among patients with HTn and history of BPH, suggesting them as prominent future markers for prediction of Pc risk.